Sigma-Aldrich Corp. announced in April that it has acquired all outstanding shares of Cleveland, Ohio-based, Research Organics
Inc., to expand the company’s buffer production capacity and to increase its portfolio of PharmaGrade raw materials for the biopharmaceutical and diagnostic
Transparent Inc. and Molecular Response Laboratories (MRL) announced in late March that they launch Cell-able
Oncology, a novel 3D cell culture system for pharmaceutical researchers and medical professionals.
In March, Michigan’s House Appropriations Subcommittee on Higher Education said it may withhold $7 million of performance funding from the 2012/2013 state budget for the University of Michigan (U-M) and Michigan State University if U-M does not disclose the number of hESCs the school is using in its research.
only way we will see true, long-term success in treating diabetes is by fundamentally rethinking this disease and shifting our focus to pursue a targeted,
personalized approach to prevention, diagnosis and treatment.